Group One Trading’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-49,400
| Closed | -$1.64M | – | 8323 |
|
|
2022
Q4 | $1.64M | Buy |
49,400
+4,900
| +11% | +$158K | ﹤0.01% | 1997 |
|
|
2022
Q3 | $1.4M | Sell |
44,500
-9,900
| -18% | -$321K | ﹤0.01% | 2225 |
|
|
2022
Q2 | $1.66M | Buy |
54,400
+26,600
| +96% | +$719K | ﹤0.01% | 2227 |
|
|
2022
Q1 | $722K | Buy |
27,800
+27,400
| +6,850% | +$652K | ﹤0.01% | 3427 |
|
|
2021
Q4 | $8K | Sell |
400
-27,800
| -99% | -$533K | ﹤0.01% | 7489 |
|
|
2021
Q3 | $543K | Sell |
28,200
-6,200
| -18% | -$124K | ﹤0.01% | 4104 |
|
|
2021
Q2 | $763K | Buy |
34,400
+26,900
| +359% | +$571K | ﹤0.01% | 3725 |
|
|
2021
Q1 | $197K | Buy |
7,500
+400
| +6% | +$9.51K | ﹤0.01% | 5047 |
|
|
2020
Q4 | $133K | Buy |
7,100
+4,100
| +137% | +$76.6K | ﹤0.01% | 4358 |
|
|
2020
Q3 | $51K | Sell |
3,000
-33,600
| -92% | -$653K | ﹤0.01% | 4636 |
|
|
2020
Q2 | $852K | Buy |
36,600
+20,100
| +122% | +$291K | ﹤0.01% | 2183 |
|
|
2020
Q1 | $139K | Buy |
+16,500
| New | +$139K | ﹤0.01% | 3038 |
|
|
2019
Q1 | – | Sell |
-2,600
| Closed | -$17K | – | 5546 |
|
|
2018
Q4 | $17K | Buy |
2,600
+2,300
| +767% | +$39.2K | ﹤0.01% | 4096 |
|
|
2018
Q3 | $4K | Buy |
+300
| New | +$4.65K | ﹤0.01% | 4923 |
|
|
2017
Q4 | – | Sell |
-1,500
| Closed | -$21K | – | 5369 |
|
|
2017
Q3 | $21K | Buy |
1,500
+1,000
| +200% | +$14.3K | ﹤0.01% | 4052 |
|
|
2017
Q2 | $8K | Sell |
500
-200
| -29% | -$2.88K | ﹤0.01% | 4300 |
|
|
2017
Q1 | $10K | Buy |
+700
| New | +$9.79K | ﹤0.01% | 4126 |
|
|
2016
Q4 | – | Sell |
-12,000
| Closed | -$231K | – | 4958 |
|
|
2016
Q3 | $231K | Sell |
12,000
-5,300
| -31% | -$104K | ﹤0.01% | 2368 |
|
|
2016
Q2 | $337K | Sell |
17,300
-1,000
| -5% | -$19.6K | ﹤0.01% | 2022 |
|
|
2016
Q1 | $377K | Sell |
18,300
-12,400
| -40% | -$244K | 0.01% | 1886 |
|
|
2015
Q4 | $630K | Buy |
30,700
+17,600
| +134% | +$337K | 0.01% | 1629 |
|
|
2015
Q3 | $224K | Buy |
13,100
+8,800
| +205% | +$161K | ﹤0.01% | 2424 |
|
|
2015
Q2 | $80K | Hold |
4,300
| – | – | ﹤0.01% | 3231 |
|
|
2015
Q1 | $82K | Buy |
+4,300
| New | +$79.5K | ﹤0.01% | 3026 |
|
Other funds holding VIVO
Group One Trading's VIVO Position: Q3 2021 in Review
Group One Trading sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 6,180 shares — an estimated $123K sold.
Group One Trading first reported a position in VIVO in Q3 2014 and held it in 13 quarters. The position peaked at $1.04M in Q3 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.
- Group One Trading reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
- Group One Trading sold 6,180 Meridian Bioscience Inc shares in Q3 2021, an estimated $123K.
- Group One Trading first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 13 quarters.
- Group One Trading's Meridian Bioscience Inc position peaked at $1.04M in Q3 2020.
- 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.
Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.